Alice Johnson
Community Health · Detroit, MINPI 1558615419
Payments from drug & device makers
Across 303 payments — averaging $27.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$3K
- Gilead$2K
- Merck$617
- Johnson & Johnson$501
- Janssen Products, LP$219
- AbbVie$151
- plus $1K from 16 others
What the payments were for
- Speaking & faculty fees$350%
- Food & beverage$8,05797%
- Education$1992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 155 | $3,206 |
| Gilead | 61 | $2,281 |
| Merck | 23 | $617 |
| Johnson & Johnson(2 entities) | 25 | $501 |
| Janssen Products, LP | 2 | $219 |
| AbbVie | 3 | $151 |
| Shionogi Inc | 5 | $128 |
| Sanofi | 1 | $126 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| AstraZeneca | 1 | $125 |
| Biohaven Pharmaceuticals, Inc. | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $113 |
| EMD Serono, Inc. | 3 | $103 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $102 |
| Napo Pharmaceuticals Inc | 4 | $96 |
| Theratechnologies Inc. | 3 | $75 |
| Lilly USA, LLC | 4 | $70 |
| Janssen Scientific Affairs, LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Exact Sciences | 1 | $25 |
| Melinta Therapeutics, LLC | 1 | $24 |
| Lundbeck LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few community health providers in Michiganto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 131 | $508,636 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 48 | $168,172 |
| JulucaDolutegravir/Rilpivirine | 35 | $122,875 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 18 | $82,411 |
| DovatoDolutegravir Sodium/Lamivudine | 16 | $44,340 |
| TivicayDolutegravir Sodium | 19 | $43,836 |
| DelstrigoDoravirine/Lamivu/Tenofov Diso | 11 | $27,710 |
| Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med | 21 | $314 |
| Potassium Chloride | 17 | $99 |
| Gabapentin | 14 | $75 |
| Atorvastatin Calcium | 14 | $52 |
| Amlodipine Besylate | 35 | $43 |
| Hydrochlorothiazide | 15 | $21 |
| Simvastatin | 11 | $6 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $2,281 | $508,636131 claims |
| Viiv Healthcare CompanyJuluca, Dovato, Tivicay | $3,206 | $211,05170 claims |
| Janssen Products, LPSymtuza | $219 | $82,41118 claims |
| MerckDelstrigo | $617 | $27,71011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few community health providers in Michiganon file to place this against a meaningful peer group, so we don't.
Other community health in Detroit
- Amanda BartonMc Bain$248
- Gale Ellis-JohnsonSouthfield$124
- Rosemary BlashillSault Sainte Marie$53
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.